Product information

Eprex 8000 IU/0,8 ml
6 x 0.8 ml
epoëtine alfa
1661586
0 / 10
Locked

Product properties

113427-24-0
B03XA01
Janssen-Cilag
Solution for injection
€364.45
BE220631
05413868105209
M42
Public
220631-01

Pharmacist Assessment

Chronically unavailable product

This product is officially available but is structurally not or barely supplied (current score 0/10, historical score 🔒/10). Consider using a structural alternative.

No available alternative found in the system. Consult the physician for a therapeutic alternative.
Note: commercialization of this product will be stopped on 31/03/2027.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 0 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Planned
From 31/03/2027

Commercial reasons

Adaptation of the treatment is possible
Available Active
Until 30/03/2027

Composition

5 ingredients

Substance Type Strength CAS
Active ingredient
5000 [iU]
113427-24-0
Excipient
1.12 mg
Excipient
0.58 mg
Excipient
2.19 mg
Excipient
0.15 mg

Additional information

Availability statistics

Available
0 days
2
0